Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB511 in Advanced Solid Tumors
NCT06400160Phase 2Not yet recruiting
- Sponsor
- Twinpig Biolab, Inc.
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules, Peptide-Drug Conjugates
01
Overview
A Phase 2 trial of tb511 in solid tumor (advanced stage), sponsored by Twinpig Biolab, Inc.. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
tb511
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06400160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400160.